医学档案

  • 国际标准期刊号: 1698-9465
  • 期刊 h 指数: 26
  • 期刊引用分数: 9.83
  • 期刊影响因子: 7.03
索引于
  • Genamics 期刊搜索
  • 中国知网(CNKI)
  • 引用因子
  • 西马戈
  • 电子期刊图书馆
  • 研究期刊索引目录 (DRJI)
  • OCLC-WorldCat
  • 普罗奎斯特传票
  • 大学教育资助委员会
  • 日内瓦医学教育与研究基金会
  • 谷歌学术
  • 夏尔巴罗密欧
  • 秘密搜索引擎实验室
分享此页面

抽象的

Perfil Clínico de Pacientes con Síndrome de Guillain Barre en un Hospital Universitario en Colombia

Jorge Mario Palmezano Díaz,Reynaldo Mauricio Rodríguez Amaya*, Diego Alejandro Rangel Rivera, Silvia Juliana Galvis Blanco, William Alejandro Camargo Ariza, Claudia Lucia Figueroa Pineda, Gustavo Pradilla Ardila, Stephany Mayerly Cristancho Vasquez, Jenny Paola Coha Diaz

Introduction: Guillain-Barré Syndrome (GBS) is defined as progressive polyradiculoneuropathy characterized by the presence of flaccid paralysis with symmetrical limb weakness associated with hyporeflexia or arreflexia. It is estimated that an incidence varies between 0.20-3.23 cases per 100,000 inhabitants around the world.
Methods and design: A retrospective cross-sectional descriptive study. The study population was conformed by all the patients that entered a University Hospital of Colombia between 2012-2016. Patients younger than 13 years or who had an incomplete medical history were excluded.
Results: A total of 55 patients were analyzed. The median age was 45 years and the median time toevolution was 5 days. Sixty percent of the patients were men. The presence of motor involvement, the initial distal involvement and the presence of decreased reflexes were present in more than 90% of the cases. There were no deaths in the hospital setting.
Conclusion: The clinical characteristics found are similar to those described in the world literature. Despite the risk of ventilatory failure of these patients and the need for admission to an intensive care unit, no fatal cases were reported. The clinical presentation in this group of patients is typical, fulfilling Brighton diagnostic criteria in most cases with certainty level 1. Most patients are managed with immunoglobulin with good clinical response.